Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,135.65
+19.951.79%
Volume:437.43K
Turnover:498.75M
Market Cap:1.07T
PE:38.12
High:1,153.45
Open:1,142.20
Low:1,130.50
Close:1,115.70
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:2.03
T/O Rate:0.05%
Dividend:6.69
Dividend Rate:0.59%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:31.69
PE(LYR):49.48

Loading ...

Lilly Q2 Adjusted EPS USD 8.38 Vs. IBES Estimate USD 6.01

Reuters
·
Aug 05

Lilly Q2 2026 Earnings: Mounjaro and Zepbound Drive 48% Revenue Growth

TradingKey
·
Aug 05

Lilly Beats Estimates on Resilient Demand for Injectable GLP-1 Drugs, Widens Gap with Novo

Reuters
·
Aug 05

Lilly Climbs on Annual Revenue Forecast Raise

Reuters
·
Aug 05

GUIDANCE: (LLY) Eli Lilly Expects 2026 Revenue Range $85B to $87B, vs. FactSet Est of $85.28B

MT Newswires Live
·
Aug 05

Eli Lilly Shares up 4.3% Premarket After Q2 Results Beat Estimates

THOMSON REUTERS
·
Aug 05

Eli Lilly Q2 FY26 EPS Rises 26% to $7.94; Revenue Increases 48% to $23 Billion

Reuters
·
Aug 05

Stock Track | Eli Lilly Soars 5.11% in Pre-market on CVS GLP-1 Partnership and Novo Nordisk Pipeline Setbacks

Stock Track
·
Aug 05

Eli Lilly Q2 Adj. EPS $8.38 Beats $6.01 Estimate, Sales $22.974B Beat $20.725B Estimate

Benzinga Earnings
·
Aug 05

Lilly Outlook FY Revenue USD 85,000-87,000 Million

THOMSON REUTERS
·
Aug 05

Eli Lilly: Asset Impairment, Restructuring and Other Special Charges of $703 Mln in Q2 2026

THOMSON REUTERS
·
Aug 05

Lilly Q2 Mounjaro Revenue USD 9,943 Million

THOMSON REUTERS
·
Aug 05

Lilly - Q2 U.S. Zepbound Revenue Increased 44% to $4.9 Billion

THOMSON REUTERS
·
Aug 05

Lilly Outlook FY Adjusted EPS USD 35.5-36.5

THOMSON REUTERS
·
Aug 05

CVS Health Raises Earnings Outlook and Launches Lilly Partnership. the Stock Jumps.

Dow Jones
·
Aug 05

Morning BID Americas-Outer SpaceX

Reuters
·
Aug 05

CVS Health Launches Eli Lilly GLP-1 Partnership, Lifts Outlook as 2Q Profit Increases

Dow Jones
·
Aug 05

CVS Health Corp: Co & Lilly Collaborating to Help Eligible Zepbound and Foundayo Patients More Easily Access Transparent Pricing

THOMSON REUTERS
·
Aug 05

European Shares Hover Near Record Highs as Earnings Offset Mideast Uncertainty

Reuters
·
Aug 05

Eli Lilly Raises Annual Revenue Forecast as GLP-1 Drugs Fuel Growth

Reuters
·
Aug 05